0001069530-22-000039.txt : 20220824 0001069530-22-000039.hdr.sgml : 20220824 20220824160205 ACCESSION NUMBER: 0001069530-22-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220823 FILED AS OF DATE: 20220824 DATE AS OF CHANGE: 20220824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kupiec James William CENTRAL INDEX KEY: 0001839551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29959 FILM NUMBER: 221191533 MAIL ADDRESS: STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 260 CITY: AUSTIN STATE: TX ZIP: 78731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASSAVA SCIENCES INC CENTRAL INDEX KEY: 0001069530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911911336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 260 CITY: AUSTIN STATE: TX ZIP: 78731 BUSINESS PHONE: 512-501-2444 MAIL ADDRESS: STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 260 CITY: AUSTIN STATE: TX ZIP: 78731 FORMER COMPANY: FORMER CONFORMED NAME: PAIN THERAPEUTICS INC DATE OF NAME CHANGE: 20000309 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2022-08-23 0001069530 CASSAVA SCIENCES INC SAVA 0001839551 Kupiec James William C/O CASSAVA SCIENCES, INC. 7801 N CAPITAL OF TEXAS HWY, SUITE 260 AUSTIN TX 78731 0 1 0 0 Chief Clinical Dev. Officer Common Stock 2022-08-23 4 P 0 2500 24.44 A 2500 D The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. /s/JAMES KUPIEC 2022-08-24